Using Consent Orders In Mass Tort Litigation

Law360, New York (July 20, 2011, 1:54 PM EDT) -- For varying reasons, both plaintiff and defense counsel continue to explore the precise scope of federal regulations with respect to the redaction of identifying information frequently found in the types of documents at issue in pharmaceutical and medical device actions, typically in the context of mass tort litigation.

From the perspective of the plaintiffs’ bar, unredacted documents can provide a gold mine of potential new clients and witnesses. From the defense side, the desire to prevent this type of access is weighed against the reality that...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.